These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 709087)

  • 1. Poliomyelitis vaccines: killed or live?
    Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantages and disadvantages of killed and live poliomyelitis vaccines.
    Melnick JL
    Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killed and live poliovirus vaccines.
    Beale AJ
    Rev Infect Dis; 1980; 2(6):960-1. PubMed ID: 7221352
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remarks on spontaneous or acquired antipoliomyelitic serologic immunity induced by the inactivated or attenuated vaccines].
    Martin R; Courillon J
    Bull Acad Natl Med; 1970 Oct; 154(26):672-81. PubMed ID: 4929254
    [No Abstract]   [Full Text] [Related]  

  • 6. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advantages and disadvantages of antipoliomyelitis vaccines prepared with live and killed viruses].
    Melnick JL
    Bol Oficina Sanit Panam; 1980 Jun; 88(6):507-29. PubMed ID: 6448065
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliomyelitis vaccination--choosing a wise policy.
    Salk J
    Pediatr Infect Dis J; 1987 Oct; 6(10):889-93. PubMed ID: 3696820
    [No Abstract]   [Full Text] [Related]  

  • 10. The IABS supporting the work of the World Health Organization--the eradication of poliomyelitis.
    Mérieux C
    Dev Biol Stand; 1999; 100():9-10. PubMed ID: 10616170
    [No Abstract]   [Full Text] [Related]  

  • 11. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V; Haenzel I; Sturm W
    Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a need for a change in poliomyelitis immunization policy?
    Sabin AB
    Pediatr Infect Dis J; 1987 Oct; 6(10):887-9. PubMed ID: 3696819
    [No Abstract]   [Full Text] [Related]  

  • 14. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against poliomyelitis in France. 1983 experience and new trends].
    Celers J
    Ann Pediatr (Paris); 1984 Jun; 31(6):471-5. PubMed ID: 6465800
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the vaccination against polio by live attenuated virus].
    Becker Y
    Harefuah; 1977 Dec; 93(12):419-21. PubMed ID: 611063
    [No Abstract]   [Full Text] [Related]  

  • 18. Poliomyelitis vaccines. Success and controversy.
    LaForce FM
    Infect Dis Clin North Am; 1990 Mar; 4(1):75-83. PubMed ID: 2407779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].
    Melnick JL
    Bull World Health Organ; 1978; 56(5):677-98. PubMed ID: 310715
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.